Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection.
Gilmour G, Porcelli S, Bertaina-Anglade V, Arce E, Dukart J, Hayen A, Lobo A, Lopez-Anton R, Merlo Pich E, Pemberton DJ, Havenith MN, Glennon JC, Harel BT, Dawson G, Marston H, Kozak R, Serretti A. Gilmour G, et al. Among authors: dawson g. Neurosci Biobehav Rev. 2019 Feb;97:47-69. doi: 10.1016/j.neubiorev.2018.09.025. Epub 2018 Nov 3. Neurosci Biobehav Rev. 2019. PMID: 30399355 Free article. Review.
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients.
Jongs N, Penninx B, Arango C, Ayuso-Mateos JL, van der Wee N, Rossum IW, Saris IMJ, van Echteld A, Koops S, Bilderbeck AC, Raslescu A, Dawson GR, Sommer B, Marston H, Vorstman JA, Eijkemans MJ, Kas MJ. Jongs N, et al. J Psychiatr Res. 2022 Jan;145:302-308. doi: 10.1016/j.jpsychires.2020.11.013. Epub 2020 Nov 9. J Psychiatr Res. 2022. PMID: 33221026 Free article.
Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol.
Bilderbeck AC, Raslescu A, Hernaus D, Hayen A, Umbricht D, Pemberton D, Tiller J, Søgaard B, Sambeth A, van Amelsvoort T, Reif A, Papazisis G, Pérez V, Elices M, Maurice D, Bertaina-Anglade V, Dawson GR, Pollentier S. Bilderbeck AC, et al. Among authors: dawson gr. Front Psychiatry. 2020 Nov 5;11:536112. doi: 10.3389/fpsyt.2020.536112. eCollection 2020. Front Psychiatry. 2020. PMID: 33250788 Free PMC article.
Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer's disease.
Saris IMJ, Aghajani M, Reus LM, Visser PJ, Pijnenburg Y, van der Wee NJA, Bilderbeck AC, Raslescu A, Malik A, Mennes M, Koops S, Arrango C, Ayuso-Mateos JL, Dawson GR, Marston H, Kas MJ, Penninx BWJH; PRISM consortium. Saris IMJ, et al. World J Biol Psychiatry. 2022 Mar-Apr;23(4):264-277. doi: 10.1080/15622975.2021.1966714. Epub 2021 Sep 17. World J Biol Psychiatry. 2022. PMID: 34378488
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders.
de la Torre-Luque A, Viera-Campos A, Bilderbeck AC, Carreras MT, Vivancos J, Diaz-Caneja CM, Aghajani M, Saris IMJ, Raslescu A, Malik A, Clark J, Penninx BWJH, van der Wee N, Rossum IW, Sommer B, Marston H, Dawson GR, Kas MJ, Ayuso-Mateos JL, Arango C. de la Torre-Luque A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110463. doi: 10.1016/j.pnpbp.2021.110463. Epub 2021 Oct 27. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34718073
Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
Saris IMJ, Aghajani M, Jongs N, Reus LM, van der Wee NJA, Bilderbeck AC, Winter van Rossum I, Arango C, de la Torre-Luque A, Malik A, Raslescu A, Dawson GR, Ayuso-Mateos JL, Kas MJ, Penninx BWJH. Saris IMJ, et al. PLoS One. 2022 Apr 14;17(4):e0263769. doi: 10.1371/journal.pone.0263769. eCollection 2022. PLoS One. 2022. PMID: 35421108 Free PMC article.
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.
Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB. Brown AJH, et al. Among authors: dawson gr. Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001. Cell. 2021. PMID: 34822784 Free article. Clinical Trial.
1,140 results